"Telemedicine and Health System Strengthening: An ANOVA-Based Study on Access, Outcomes, and Satisfaction"

Telemedicine has emerged as a transformative tool for enhancing healthcare accessibility, particularly in underserved and remote areas. This study assesses the effectiveness of telemedicine technologies in improving patient care, disease management, and overall health system performance from the perspective of medical professionals. A cross-sectional survey was conducted among 247 doctors using a structured and reliable questionnaire (Cronbach’s alpha = 0.872). Paired samples t-tests and ANOVA were employed to evaluate perceptual changes before and after telemedicine awareness interventions. Results indicated significant improvements in doctors’ confidence regarding telemedicine’s role in diagnosing and managing conditions such as tuberculosis, chronic obstructive pulmonary disease (COPD), malaria, and COVID-19. ANOVA revealed statistically significant differences across three thematic domains: Patient Care Improvement (PCI), Disease Cure Improvement (DCI), and Health System Improvement (HSI). While telemedicine is widely supported for routine and chronic care, limitations remain in its application to complex treatment scenarios. The findings highlight telemedicine’s potential to enhance healthcare delivery and emphasize the need for targeted training and infrastructure development to facilitate its effective integration into health systems.

To assess the effectiveness of telemedicine technologies in enhancing healthcare delivery, with specific emphasis on accessibility, treatment outcomes, and systemic health improvements, as perceived by medical professionals. Competing Interest Statement The authors have declared no competing interest. Funding Statement This study did not receive any funding Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approval for the study was obtained from the JSPH-Institutional Review Board (Approval Number: [100032-IRB/20-21]). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript